Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsKeith Wheatley, Stefan Suciu, Natalie Ives et al.|Cancer Treatment Reviews|2003Cited by 344
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.U. Keilholz, Maria Pritsch, Christian Conradt et al.|Journal of Clinical Oncology|1998Cited by 199
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysisNatalie Ives, Stefan Suciu, Alexander M.M. Eggermont et al.|European Journal of Cancer|2017Cited by 170